Back

Intra-Cellular Therapies Quote, Financials, Valuation and Earnings

Sell

ITCI
Intra-Cellular Therapies

Last Price:

65.60

Seasonality Move:

-0.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Intra-Cellular Therapies Price Quote

$65.60

-0.93 (-1.4%)

(Updated: May 17, 2024 at 11:25 AM ET)

Intra-Cellular Therapies Key Stats

Sell

Intra-Cellular Therapies (ITCI) is a Sell

Day range:

$65.51 - $67.10

52-week range:

$45.50 - $84.89

Dividend yield:

P/E ratio:

0.00

P/S ratio:

12.51

P/B ratio:

11.72%

Volume:

723.4K

Avg. volume:

1.2M

1-year change:

5.37%

Market cap:

$7B

Revenue:

$462.2M

EPS:

$-1.16

How Much Does Intra-Cellular Therapies Make?

How Much Are Intra-Cellular Therapies's Sales Annually?
ITCI Revenues are $462.2M
How Much Profit Does Intra-Cellular Therapies's Make A Year?
ITCI net income is -$139.7M

Is Intra-Cellular Therapies Growing As A Company?

What Is Intra-Cellular Therapies's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.53%
What Is Intra-Cellular Therapies's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Intra-Cellular Therapies Stock Price Performance

Did Intra-Cellular Therapies Stock Go Up Last Month?
Intra-Cellular Therapies share price went down by -16.67% last month
Did ITCI's Share Price Rise Over The Last Year?
ITCI share price rose by 5.37% over the past 1 year

What Is Intra-Cellular Therapies 52-Week High & Low?

What Is Intra-Cellular Therapies’s 52-Week High Share Price?
Intra-Cellular Therapies has traded as high as $84.89 over the past 52 weeks
What Is Intra-Cellular Therapies’s 52-Week Low Share Price?
Intra-Cellular Therapies has traded as low as $45.50 over the past 52 weeks

Intra-Cellular Therapies Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Intra-Cellular Therapies?

How Much Debt Does Intra-Cellular Therapies Have?
Total long term debt quarterly is $0
How Much Cash Does Intra-Cellular Therapies Have?
Cash and short term investments quarterly total is $475.6M
What Is Intra-Cellular Therapies’s Book Value Per Share?
Book value per share is 6.15

Is Intra-Cellular Therapies Cash Flow Positive?

What Is ITCI Cash Flow From Operations?
Cash flow from operations (TTM) is -$98.2M
What Is Intra-Cellular Therapies’s Cash Flow From Financing?
Cash flow from financing (TTM) is $24.2M
What Is Intra-Cellular Therapies’s Cash Flow From Investing?
Cash flow from investing (TTM) is $138.2M

Intra-Cellular Therapies Return On Invested Capital

Is Management Doing A Good Job?
ITCI return on invested capital is -18.32%
What Is Intra-Cellular Therapies Return On Assets?
ROA measures how assets are converting to revenues and is -15.28%
What Is ITCI Return On Equity?
ROE is a measure of profitability and is -18.32%

Intra-Cellular Therapies Earnings Date & Stock Price

What Is Intra-Cellular Therapies's Stock Price Today?
A single share of ITCI can be purchased today for 66.53
What Is Intra-Cellular Therapies’s Stock Symbol?
Intra-Cellular Therapies trades on the nasdaq under the ticker symbol: ITCI
When Is Intra-Cellular Therapies’s Next Earnings Date?
The next quarterly earnings date for Intra-Cellular Therapies is scheduled on August 2, 2024
When Is ITCI's next ex-dividend date?
Intra-Cellular Therapies's next ex-dividend date is May 26, 2020
How To Buy Intra-Cellular Therapies Stock?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Intra-Cellular Therapies Competitors

Who Are Intra-Cellular Therapies's Competitors?
Below is a list of companies who compete with Intra-Cellular Therapies or are related in some way:
- Fate Therapeutics Inc (FATE)
- Insmed Inc (INSM)
- Johnson & Johnson (JNJ)
- Madrigal Pharmaceuticals Inc (MDGL)
- Vertex Pharmaceuticals Inc (VRTX)

Intra-Cellular Therapies Dividend Yield